Bioengineering

Neurotech Names Richard Small Chief Financial Officer

Published in Law and Health Weekly, August 25th, 2007

Neurotech Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of sight-saving therapeutics for chronic retinal diseases, announced the appointment of Richard Small as the Company's Vice President and Chief Financial Officer (CFO).

Mr. Small brings more than fifteen years of senior-level strategic management in both private and public life sciences companies and thirty years of financial and operational management to Neurotech. Previously, Mr. Small served as Senior Vice President, CFO of publicly-traded Point Therapeutics where he was involved in raising in excess of $100 million. Prior to that, he served as CFO at Immulogic Pharmaceutical. A...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2007-08-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry